156 related articles for article (PubMed ID: 25363150)
1. Clinico-biological characteristics and treatment of type I monoclonal cryoglobulinaemia: a study of 64 cases.
Harel S; Mohr M; Jahn I; Aucouturier F; Galicier L; Asli B; Malphettes M; Szalat R; Brouet JC; Lipsker D; Fermand JP
Br J Haematol; 2015 Mar; 168(5):671-8. PubMed ID: 25363150
[TBL] [Abstract][Full Text] [Related]
2. [Cutaneous manifestations revealing cryofibrinogenaemia associated with monoclonal gammopathy].
Delyon J; Bezier M; Cordoliani F; Malphettes M; Szalat R; Bagot M; Rybojad M
Ann Dermatol Venereol; 2013 Jan; 140(1):30-5. PubMed ID: 23328357
[TBL] [Abstract][Full Text] [Related]
3. Glomerular lesions in monoclonal gammopathies and mixed essential cryoglobulinemias IgG-IgM.
Verroust P; Mery JP; Morel-Maroger L; Clauvel JP; Richet G; Bouteiller AM; Fumagalli N
Adv Nephrol Necker Hosp; 1971; 1():161-94. PubMed ID: 4377644
[TBL] [Abstract][Full Text] [Related]
4. Clinical and clonal characteristics of monoclonal immunoglobulin M-associated type I cryoglobulinaemia.
Khwaja J; Vos JMI; Pluimers TE; Japzon N; Patel A; Salter S; Kwakernaak AJ; Gupta R; Rismani A; Kyriakou C; Wechalekar AD; D'Sa S
Br J Haematol; 2024 Jan; 204(1):177-185. PubMed ID: 37726004
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic framing of IgM monoclonal gammopathy: Focus on Waldenström macroglobulinemia.
Tedeschi A; Conticello C; Rizzi R; Benevolo G; Laurenti L; Petrucci MT; Zaja F; Varettoni M
Hematol Oncol; 2019 Apr; 37(2):117-128. PubMed ID: 30192023
[TBL] [Abstract][Full Text] [Related]
6. Long-term outcome of monoclonal (type 1) cryoglobulinemia.
Néel A; Perrin F; Decaux O; Dejoie T; Tessoulin B; Halliez M; Mahé B; Lamy T; Fakhouri F; Jego P; Agard C; Vigneau C; Guenet L; Grosbois B; Moreau P; Hamidou M
Am J Hematol; 2014 Feb; 89(2):156-61. PubMed ID: 24532335
[TBL] [Abstract][Full Text] [Related]
7. Monoclonal gammopathy: natural history studied with a retrospective approach.
Steingrimsdottir H; Haraldsdottir V; Olafsson I; Gudnason V; Ogmundsdottir HM
Haematologica; 2007 Aug; 92(8):1131-4. PubMed ID: 17650445
[TBL] [Abstract][Full Text] [Related]
8. [Arndt-Gottron scleromyxedema and associated phenomena].
Lang E; Zabel M; Schmidt H
Dermatologica; 1984; 169(1):29-35. PubMed ID: 6432594
[TBL] [Abstract][Full Text] [Related]
9. Malignant transformation in IgM monoclonal gammopathy of undetermined significance.
Montoto S; Rozman M; Rosiñol L; Nadal E; Giné E; Aymerich M; Ferrer A; Esteve J; Bosch F; López-Guillermo A; Bladé J; Montserrat E
Semin Oncol; 2003 Apr; 30(2):178-81. PubMed ID: 12720132
[TBL] [Abstract][Full Text] [Related]
10. Maintenance Rituximab is associated with improved clinical outcome in rituximab naïve patients with Waldenstrom Macroglobulinaemia who respond to a rituximab-containing regimen.
Treon SP; Hanzis C; Manning RJ; Ioakimidis L; Patterson CJ; Hunter ZR; Sheehy P; Turnbull B
Br J Haematol; 2011 Aug; 154(3):357-62. PubMed ID: 21615385
[TBL] [Abstract][Full Text] [Related]
11. CANOMAD: a neurological monoclonal gammopathy of clinical significance that benefits from B-cell-targeted therapies.
Le Cann M; Bouhour F; Viala K; Simon L; Tard C; Rossi C; Morel G; Lagrange E; Magy L; Créange A; Michaud M; Franques J; Echaniz-Laguna A; Antoine JC; Baron M; Arnulf B; Puma A; Delmont E; Maisonobe T; Leblond V; Roos-Weil D
Blood; 2020 Nov; 136(21):2428-2436. PubMed ID: 32959046
[TBL] [Abstract][Full Text] [Related]
12. Mixed cryoglobulinaemia not related to hepatitis C virus, mesangiocapillary glomerulonephritis and lymphoplasmocytic lymphoma.
Martina MN; Solé M; Massó E; Pérez N; Campistol JM; Quintana LF
Nefrologia; 2011; 31(6):743-6. PubMed ID: 22130292
[TBL] [Abstract][Full Text] [Related]
13. Long-term follow-up of IgM monoclonal gammopathy of undetermined significance.
Kyle RA; Therneau TM; Rajkumar SV; Offord JR; Larson DR; Plevak MF; Melton LJ
Semin Oncol; 2003 Apr; 30(2):169-71. PubMed ID: 12720130
[TBL] [Abstract][Full Text] [Related]
14. Prognostic validation of the international classification of immunoglobulin M gammopathies: a survival advantage for patients with immunoglobulin M monoclonal gammopathy of undetermined significance?
Gobbi PG; Baldini L; Broglia C; Goldaniga M; Comelli M; Morel P; Morra E; Cortelazzo S; Bettini R; Merlini G
Clin Cancer Res; 2005 Mar; 11(5):1786-90. PubMed ID: 15756000
[TBL] [Abstract][Full Text] [Related]
15. Neuropathy associated with monoclonal gammopathies of undetermined significance.
Gosselin S; Kyle RA; Dyck PJ
Ann Neurol; 1991 Jul; 30(1):54-61. PubMed ID: 1656848
[TBL] [Abstract][Full Text] [Related]
16. [Leg ulcer associated with type I cryoglobulinaemia due to incipient B-cell lymphoma].
Lacoste C; Duong TA; Dupuis J; Haioun C; Plonquet A; Copie-Bergman C; Gaulard P; Ortonne N
Ann Dermatol Venereol; 2013 May; 140(5):367-72. PubMed ID: 23663709
[TBL] [Abstract][Full Text] [Related]
17. [Type I cryoglobulinemia with a fatal outcome].
Echeverría B; Vitiello M; Abuchar A; Kerdel FA
Actas Dermosifiliogr; 2011 Apr; 102(3):212-5. PubMed ID: 21376295
[TBL] [Abstract][Full Text] [Related]
18. Pentostatin/cyclophosphamide with or without rituximab: an effective regimen for patients with Waldenstrom's macroglobulinemia/lymphoplasmacytic lymphoma.
Hensel M; Villalobos M; Kornacker M; Krasniqi F; Ho AD
Clin Lymphoma Myeloma; 2005 Sep; 6(2):131-5. PubMed ID: 16231851
[TBL] [Abstract][Full Text] [Related]
19. Serum concentrations of angiogenic cytokines in Waldenstrom macroglobulinaemia: the ration of angiopoietin-1 to angiopoietin-2 and angiogenin correlate with disease severity.
Anagnostopoulos A; Eleftherakis-Papaiakovou V; Kastritis E; Tsionos K; Bamias A; Meletis J; Dimopoulos MA; Terpos E
Br J Haematol; 2007 Jun; 137(6):560-8. PubMed ID: 17451406
[TBL] [Abstract][Full Text] [Related]
20. The value of serum free light chains in a case of Waldenstrom's macroglobulinaemia that produces a type I cryoglobulinaemia.
Pattenden RJ; Davidson KL; Wenham PR
Ann Clin Biochem; 2009 Nov; 46(Pt 6):531-2. PubMed ID: 19822697
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
